Mucoactives for acute respiratory failure in the critically ill: A protocol for a systematic review

Research output: Other contributionProtocol

Abstract

The primary objective of this review is to determine whether the use of mucoactive agents for ARF in critically ill patients is effective in improving clinically important outcomes including duration of ventilation and intubation rate. Secondary objectives include, to explore benefit in subgroups based on their reason for ARF, if any specific conditions benefit with a specific mucoactive agent, which mucoactive agent has most evidence and what outcomes are most frequently impacted.
Original languageEnglish
TypeProtocol
PublisherPROSPERO
Publication statusPublished - 23 May 2018

Fingerprint

Dive into the research topics of 'Mucoactives for acute respiratory failure in the critically ill: A protocol for a systematic review'. Together they form a unique fingerprint.

Cite this